Number of Shares
2,638.00
Current Holdings Value*
kr176,380.00
% of Portfolio
0.03%
Total Estimate Gain
kr6.02 Mil
% of Total Estimate Gain
38.60%

STRATEGIC ALLOCATION: MODERATE FUND's Novo Nordisk AS Holding Summary

As of 2025-04-30, AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC held 2,638.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr176,380.00. This investment constitutes 0.03% of their stock portfolio, and AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. And since then STRATEGIC ALLOCATION: MODERATE FUND has made 5 purchases of OCSE:NOVO B, at an average price of kr342.94, for a total of 45,509.00 shares. In addition, there have been 13 sales at an average price of kr478.48 for 42,871.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr424.00, STRATEGIC ALLOCATION: MODERATE FUND's estimated gain on his OCSE:NOVO B holdings is kr6.02 Mil, reflecting a 38.60% gain to date.

STRATEGIC ALLOCATION: MODERATE FUND OCSE:NOVO B (kr424.00) Holding Chart

STRATEGIC ALLOCATION: MODERATE FUND OCSE:NOVO B (kr424.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1